Outcomes of Patients with R/R B-Cell NHL and Limited (<5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy.”
Dr. Omran Saifi is the Chief Radiation Oncology Resident at Mayo Clinic, where he specializes in the treatment of cancer using radiation therapy. He serves as a liaison to the Florida Society of Clinical Oncology (FLASCO) and is an Associate Editor for theMednet. His research and academic interests include CAR T-cell therapy, lymphoma, and cancers of the breast, lung, and head and neck.